Retraction
Identification of Paxillin as a Prognostic Factor for Glioblastoma via Integrated Bioinformatics Analysis
Paper Information
Record ID:
60652
Author(s):
Journal:
Publication Date:
June 23, 2022
Retraction Date:
November 29, 2023
(2.0 year years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (5)
5
Total Citations0
Post-Retraction4
Pre-Retraction0
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Disease-Based Prognostication: Neuro-Oncology
Kristin Waite, Gino Cioffi, Mark G. Malkin et al. (4 authors)
Seminars in Neurology
Published: Sep 2023
2 citations
2 citations
64 days before retraction
Cdk4 Regulates Glioblastoma Cell Invasion and Stemness and Is Target of a Notch Inhibitor Plus Resveratrol Combined Treatment
Francesca Giordano, Maria D’Amico, Francesca Montalto et al. (10 authors)
International Journal of Molecular Sciences
Open Access
Published: Jun 2023
8 citations
8 citations
169 days before retraction
The Role of Paxillin Aberrant Expression in Cancer and Its Potential as a Target for Cancer Therapy
W. Liu, X J Huang, Weizhao Luo et al. (5 authors)
International Journal of Molecular Sciences
Open Access
Published: May 2023
10 citations
10 citations
209 days before retraction
Retracted: Identification of Paxillin as a Prognostic Factor for Glioblastoma via Integrated Bioinformatics Analysis
BioMed Research International
BioMed Research International
Open Access
Published: Jan 2023
332 days before retraction
Quick Stats
Total Citations:
8
Years Since Retraction:
2.0 year
Open Access:
Yes
Last Checked:
Jul 24, 2025